Tuesday, August 4, 2026

SBE303: The Next-Gen ADC Cancer Drug Revolutionizing Treatment in 2026

Samsung Bioepis presents promising results for SBE303, a next-gen ADC targeting nectin-4, showing improved efficacy and safety in trials.

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

How U.S. Naval Protection in Hormuz is Impacting Global Oil Prices: A Deep Dive

International oil prices decline as U.S. commits to escort vessels through the Strait of Hormuz amid tensions with Iran.

Tag: Paul Graham

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.